Archives

  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-04
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Solanesol Technical Guidance: Handling and Research Workflow

    2026-07-19

    Solanesol Technical Guidance: Handling and Research Workflows

    What This Product Solves

    Solanesol is a naturally occurring polyisoprenoid alcohol (C45H74O, MW 631.09) that offers precise utility in research requiring high-purity, hydrophobic compounds. Its structure and physicochemical properties are directly relevant to studies of membrane-associated biological processes. Researchers utilize Solanesol primarily as a model compound or precursor in the context of:

    • Apoptosis research, where membrane integrity and signaling are pivotal.
    • DNA damage and repair studies, particularly those involving mitochondrial pathways.
    • Metabolic enzyme assays targeting isoprenoid biosynthetic processes.
    • Protease activity research where lipid environment modulation is required.

    Solanesol addresses the need for a well-characterized, hydrophobic substrate or precursor in workflows where water-soluble alternatives are unsuitable. Its defined purity (98%, mass spectrometry and NMR verified) and stability profile minimize background variability and facilitate consistent experimental conditions. The product is not suitable for diagnostic, clinical, or aqueous/ethanol system applications due to its solubility limitations. For full product details, refer to the Solanesol page at APExBIO.

    Protocol Parameters

    • Solubility in DMSO: 2.64 mg/mL or higher | Compound dissolution/stock preparation | Enables accurate dosing in hydrophobic assay systems; ensures homogeneous working stocks for apoptosis, DNA repair, and metabolic enzyme workflows | product information
    • Storage Temperature: -20°C (recommended) | Long-term solid/powder storage | Preserves compound integrity and purity for consistent data across replicates and batches | product information
    • Solvent Compatibility: Insoluble in ethanol and water | Solvent selection for assay setup | Prevents precipitation, ensures full compound availability in DMSO-based systems; avoids misleading results in aqueous/ethanol-based research | product information
    • Fresh Solution Preparation: Prepare immediately before use (recommended) | Working solution for cell-based and enzyme assays | Minimizes degradation and aggregation risk in DMSO; maintains experimental reproducibility | workflow recommendation
    • Aliquoting of Powder: Use dry, pre-chilled tools; minimize exposure to air | Accurate weighing and transfer for Solanesol 100mg, 200mg, or 500mg packs | Reduces oxidative degradation and moisture uptake prior to solubilization | workflow recommendation

    Workflow Setup and QC Checklist

    • Confirm physical state and appearance of Solanesol powder upon receipt; ensure container is tightly closed and stored at -20°C.
    • Use only anhydrous DMSO for stock solution preparation. Do not attempt dissolution in ethanol or water.
    • Prepare stock solutions freshly before each use, especially for sensitive applications such as apoptosis research or metabolic enzyme assays. Discard unused stock after each session.
    • Filter sterilize stock solutions (0.22 μm PTFE recommended) if required for cell-based work; avoid aqueous dilution steps until immediately prior to addition to cell culture media.
    • Aliquot Solanesol powder for single-use where possible (e.g., Solanesol 100mg or 200mg) to limit freeze-thaw cycles and cumulative exposure to moisture/air.
    • Maintain accurate records of lot numbers, preparation dates, and storage conditions for all working stocks to facilitate troubleshooting and reproducibility.
    • Perform baseline QC checks: confirm solubility and absence of visible particulates before use in sensitive assays such as DNA damage and repair studies or protease activity research.

    For further reference on technical handling and protocol guidance, see Solanesol: Technical Handling and Protocol Guidance, which provides detail on managing hydrophobic compounds in research workflows. Additional assay-focused workflow advice is available in Solanesol: Technical Guidance for Polyisoprenoid Alcohol Research.

    Common Failure Modes and Fixes

    • Incomplete Dissolution in DMSO: Use anhydrous DMSO, vortex thoroughly, and gently heat if required (avoid prolonged heating). Confirm final concentration does not exceed solubility threshold (≥2.64 mg/mL).
    • Precipitation in Assay Buffer: Dilute DMSO stocks directly into final assay buffer immediately prior to use. Ensure rapid and uniform mixing to prevent local oversaturation; avoid holding diluted stock for extended periods.
    • Loss of Potency/Degradation: Store powder at -20°C, minimize light and air exposure, and avoid repeated freeze-thaw cycles by aliquoting. Prepare new working stock for each experiment.
    • Interference in Aqueous/Ethanol Systems: Strictly avoid these solvents for both stock and working solution preparation. Substitute or modify workflow to a DMSO-compatible format where possible.
    • Batch-to-Batch Variability: Use only products with documented purity (98%, MS/NMR validated) and maintain consistent handling between lots. Keep detailed logs of preparation and usage.

    Scope and Limitations

    Solanesol is validated for scientific research applications that require a high-purity, hydrophobic polyisoprenoid alcohol. Its use is well suited for workflows involving apoptosis signaling, DNA repair, metabolic enzyme function, and protease activity, especially where membrane context or lipid interaction is central to the biological question. However, this product is:

    • Not suitable for diagnostic or clinical applications.
    • Not compatible with water- or ethanol-based systems; only DMSO or equivalent hydrophobic solvents should be used.
    • Intended solely for laboratory research; no direct mechanistic or clinical claims are supported by current evidence.
    • For detailed handling and workflow recommendations, always consult the product dossier and relevant internal technical articles.

    Conclusion

    Solanesol (SKU B8776) provides a robust, high-purity polyisoprenoid alcohol standard for membrane-related and hydrophobic compound research, including apoptosis, DNA damage and repair, metabolic enzyme, and protease assays. Adherence to precise handling, solubility, and storage protocols is essential for consistent and reproducible results. For more details, visit the Solanesol product page at APExBIO. Utilize internal technical articles for additional workflow-specific guidance and troubleshooting advice.